Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares (represented by American Depository Shares)
-
Shares outstanding
-
72.8M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
1.15M
-
Shares change
-
-666K
-
Total reported value, excl. options
-
$16.4M
-
Value change
-
-$7.78M
-
Number of sells
-
-7
-
Price
-
$14.30
Significant Holders of Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) as of Q1 2024
9 filings reported holding ABVX - Abivax S.A. - Ordinary Shares (represented by American Depository Shares) as of Q1 2024.
Abivax S.A. - Ordinary Shares (represented by American Depository Shares) (ABVX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.15M shares
of 72.8M outstanding shares and own 1.57% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (593K shares), CITADEL ADVISORS LLC (552K shares), Financial Management Professionals, Inc. (100 shares), Point72 Middle East FZE (0 shares), FMR LLC (0 shares), Tudor Investment Corp Et Al (0 shares), AlphaCentric Advisors LLC (0 shares), Ghisallo Capital Management LLC (0 shares), MARSHALL WACE, LLP (0 shares), and Deep Track Capital, LP (4.3M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.